SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Depreciation
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) reported Depreciation of $1.04 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-11-13
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. depreciation for the quarter ending 2025-09-30 was $1.01K, a 27.11% increase year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. depreciation for the quarter ending 2025-06-30 was -$979.00, a 201.77% decline year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. depreciation for the quarter ending 2025-03-31 was $1.01K, a 47.28% decline year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. depreciation for the quarter ending 2024-12-31 was $1.80K, a 9.43% decline year-over-year.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. depreciation for fiscal 2024 was $5.46K, a 19.79% decline from fiscal 2023.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. depreciation for fiscal 2023 was $6.81K, a 14.05% increase from fiscal 2022.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. depreciation for fiscal 2022 was $5.97K, a 3.96% decline from fiscal 2021.
- SHUTTLE PHARMACEUTICALS HOLDINGS, INC. depreciation for fiscal 2021 was $6.22K.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2025-09-30 | $1.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $29.00 derived: sum of 2 quarters · filed 2025-11-13 | $1.04K 10-Q · filed 2025-11-13 | $2.83K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | -$979.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $29.00 10-Q · filed 2025-08-13 | $1.82K derived: sum of 3 quarters · filed 2025-08-13 | $2.62K derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | $1.01K 10-Q · filed 2025-05-08 | $2.80K derived: sum of 2 quarters · filed 2025-05-08 | $3.60K derived: sum of 3 quarters · filed 2025-11-13 | $4.56K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | $1.80K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $2.59K derived: sum of 2 quarters · filed 2025-11-13 | $3.55K derived: sum of 3 quarters · filed 2025-11-13 | $5.46K 10-K · filed 2025-02-26 |
| 2024-09-30 | $793.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $1.75K derived: sum of 2 quarters · filed 2025-11-13 | $3.67K 10-Q · filed 2025-11-13 | $5.65K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $962.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $2.87K 10-Q · filed 2025-08-13 | $4.86K derived: sum of 3 quarters · filed 2025-08-13 | $6.71K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $1.91K 10-Q · filed 2025-05-08 | $3.90K derived: sum of 2 quarters · filed 2025-05-08 | $5.75K derived: sum of 3 quarters · filed 2025-05-08 | $7.24K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $1.98K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $3.84K derived: sum of 2 quarters · filed 2025-02-26 | $5.32K derived: sum of 3 quarters · filed 2025-02-26 | $6.81K 10-K · filed 2025-02-26 |
| 2023-09-30 | $1.86K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $3.34K derived: sum of 2 quarters · filed 2024-11-13 | $4.83K 10-Q · filed 2024-11-13 | $6.32K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $1.48K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2024-09-04 | $2.97K 10-Q · filed 2024-09-04 | $4.46K derived: sum of 3 quarters · filed 2024-09-04 | $6.04K derived: sum of 4 quarters · filed 2024-09-04 |
| 2023-03-31 | $1.49K 10-Q/A · filed 2024-09-04 | $2.98K derived: sum of 2 quarters · filed 2024-09-04 | $4.56K derived: sum of 3 quarters · filed 2024-09-04 | $6.01K derived: sum of 4 quarters · filed 2024-09-04 |
| 2022-12-31 | $1.49K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-09-04 | $3.07K derived: sum of 2 quarters · filed 2024-09-04 | $4.52K derived: sum of 3 quarters · filed 2024-09-04 | $5.97K 10-K/A · filed 2024-09-04 |
| 2022-09-30 | $1.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $3.03K derived: sum of 2 quarters · filed 2023-11-13 | $4.48K 10-Q · filed 2023-11-13 | $6.65K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.90K 10-Q · filed 2023-08-14 | $5.07K derived: sum of 3 quarters · filed 2023-08-14 | |
| 2022-03-31 | $1.45K 10-Q · filed 2023-05-25 | $3.62K derived: sum of 2 quarters · filed 2023-05-25 | ||
| 2021-12-31 | $2.17K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $6.22K 10-K · filed 2023-03-15 | ||
| 2021-09-30 | $4.05K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |